Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial

BACKGROUND: Pruritus in patients undergoing hemodialysis is a highly prevalent complication that affects quality of life. Several medications are currently used for the treatment of uremic pruritus, but these are not satisfactory. PG102P, which is prepared from Actinidia arguta, has an immune-modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Chul, Park, Jae Yoon, Oh, Sohee, Cho, Jang-Hee, Chang, Jae Hyun, Choi, Dae Eun, Park, Jung Tak, Lee, Jung Pyo, Kim, Sejoong, Kim, Dong Ki, Ryu, Dong-Ryeol, Lim, Chun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883697/
https://www.ncbi.nlm.nih.gov/pubmed/31779697
http://dx.doi.org/10.1186/s13063-019-3753-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883697/
https://www.ncbi.nlm.nih.gov/pubmed/31779697
http://dx.doi.org/10.1186/s13063-019-3753-1

Ejemplares similares